Wutah dodolan YoY sajrone 12 wulan kepungkur: Invivyd (IVVD)

Logo perusahaan publik Invivyd Inc (IVVD)

Invivyd, Inc. (IVVD) aims for dominance in the antiviral antibody segment by scaling biodefense solutions. On GURU.Markets, the current YoY revenue growth rate over the TTM reflects the market consensus, where the current level is 26.50. The implementation of robotic screening accelerates the release of innovations, yet high viral volatility and regulatory barriers create significant financial risks for the company.

IVVD (invivyd.com) riwayat Wutah dodolan YoY (TTM) saka 11.02.2024 nganti 16.11.2026

Invivyd - rincian analitis lan metrik utama (IVVD)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:Invivyd Inc - IVVD
Produk sing diprodhuksi invivyd.com

To filter for fundamentally strong assets, an investor must separate market noise from actual business expansion. This TTM year-over-year sales growth percentage on GURU.Markets measures the annual sales rate while excluding seasonality, which for Invivyd, Inc. (IVVD) confirms the commercial effectiveness of adapting antibodies to new strains and mitigates regulatory risks through objective revenue dynamics.